ICD-10 Coding for Drug-Induced Constipation(K59.03)
Complete ICD-10-CM coding and documentation guide for Drug-Induced Constipation. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Drug-Induced Constipation
K59.0-K59.09Primary Range
Functional intestinal disorders
This range includes codes for constipation, with K59.03 specifically for drug-induced constipation.
Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
These codes are used to specify the adverse effects of drugs causing constipation.
Key Information: ICD-10 code for drug-induced constipation
Essential facts and insights about Drug-Induced Constipation
Primary ICD-10-CM Code for drug induced constipation
Decision Criteria
clinical Criteria
- Documented link between drug use and constipation onset
coding Criteria
- Use K59.03 when drug-induced nature is confirmed
Applicable To
- Opioid-induced constipation
- Constipation due to medication
Excludes
- Constipation NOS (K59.00)
Clinical Validation Requirements
- Temporal relationship between drug initiation and constipation onset
- Documentation of the causative drug
- Exclusion of other causes of constipation
Code-Specific Risks
- Incorrectly using unspecified constipation codes when drug-induced is documented
Coding Notes
- Ensure documentation specifies the drug and confirms the adverse effect relationship.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Adverse effect of other opioids
T40.2X5ADocumentation & Coding Risks
Avoid these common documentation and coding issues when documenting Drug-Induced Constipation to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code K59.03.
Impact
Clinical: Inaccurate diagnosis and treatment, Regulatory: Non-compliance with coding standards, Financial: Potential loss of reimbursement
Mitigation Strategy
Always document the drug name and its effects, Use templates to ensure completeness
Impact
Reimbursement: May result in lower reimbursement if unspecified codes are used., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.
Mitigation Strategy
Always use K59.03 when documentation supports drug-induced constipation.
Impact
Failure to document the drug causing constipation can lead to audit issues.
Mitigation Strategy
Ensure all clinical notes specify the drug and its adverse effects.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Drug-Induced Constipation, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Drug-Induced Constipation
Use these documentation templates to ensure complete and accurate documentation for Drug-Induced Constipation. These templates include all required elements for proper coding and billing.
Opioid-induced constipation
Specialty: Pain ManagementRequired Elements
- Causative drug
- Onset of symptoms
- Failed treatments
- Exclusion of other causes
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Drug-Induced Constipation? Ask your questions below.